Highbridge Capital Management’s ResMed RMD Stock Holding History

Highbridge Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,400	Closed	-$2.33M	–	282
2019 Q1	$2.33M	Buy	22,400 +14,400	+180%	+$1.49M	0.07%	215
2018 Q4	$911K	Sell	8,000 -1,400	-15%	-$150K	0.03%	270
2018 Q3	$1.08M	Buy	+9,400	New	+$1.03M	0.03%	380
2018 Q2	–	Sell	-2,512	Closed	-$247K	–	1270
2018 Q1	$247K	Buy	+2,512	New	+$237K	﹤0.01%	970
2016 Q4	–	Sell	-26,790	Closed	-$1.74M	–	1545
2016 Q3	$1.74M	Sell	26,790 -144,352	-84%	-$9.61M	0.03%	453
2016 Q2	$10.8M	Buy	171,142 +63,759	+59%	+$3.76M	0.18%	152
2016 Q1	$6.21M	Buy	+107,383	New	+$6.08M	0.1%	233
2015 Q4	–	Sell	-216,751	Closed	-$11M	–	1760
2015 Q3	$11M	Buy	216,751 +209,548	+2,909%	+$11.3M	0.17%	162
2015 Q2	$406K	Buy	+7,203	New	+$455K	0.01%	1041
2014 Q1	–	Sell	-62,303	Closed	-$2.93M	–	1219
2013 Q4	$2.93M	Buy	62,303 +50,432	+425%	+$2.55M	0.04%	340
2013 Q3	$627K	Buy	+11,871	New	+$576K	0.01%	810

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Highbridge Capital Management's RMD Position: Q2 2019 in Review

Highbridge Capital Management sold out of ResMed (RMD) in Q2 2019, closing a stake of 22,400 shares — an estimated $2.33M sold.

Highbridge Capital Management first reported a position in RMD in Q3 2013 and held it in 11 quarters. The position peaked at $11M in Q3 2015. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

Highbridge Capital Management reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
Highbridge Capital Management sold 22,400 ResMed shares in Q2 2019, an estimated $2.33M.
Highbridge Capital Management first reported a position in ResMed in Q3 2013 and held it in 11 quarters.
Highbridge Capital Management's ResMed position peaked at $11M in Q3 2015.
485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Highbridge Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.